Table 3.
Examination of Potential Confounders of the Modifying Effect of Purpose In Lifea
| Confounder | Interaction of Purpose in Life With Global AD Pathologic Changes
|
|
|---|---|---|
| Parameter Estimate (SE) | P Value | |
| Depressive symptoms (n = 246) | 0.647 (0.230) | .005 |
| Neuroticism (n = 224) | 0.464 (0.282) | .10 |
| Social network size (n = 246) | 0.566 (0.021) | .009 |
| No. of chronic medical conditions (n = 246) | 0.540 (0.213) | .009 |
| Physical activity (n = 246) | 0.584 (0.020) | .009 |
| No. of persons with an apolipoprotein ε4 allele (n = 241) | 0.459 (0.218) | .04 |
| Time to death (n = 246) | 0.570 (0.204) | .006 |
Abbreviation: AD, Alzheimer disease.
Derived from separate linear regression models adjusted for age, sex, educational level, purpose in life, and AD pathologic characteristics and the interactions of purpose and pathologic characteristics and each of the covariates and pathologic characteristics.